00512 遠大醫藥
公司資料 - 損益表
遠大醫藥集團有限公司 股票編號: 00512
GRAND PHARMACEUTICAL GROUP LIMITED 集團網址: http://www.grandpharm.com
2024/12 - 末期
港元(K$)
變動 2023/12
港元(K$)
2022/12
港元(K$)
2021/12
港元(K$)
2020/12
港元(K$)
營業額 / 收益11,644,89210.592%10,529,5909,562,2858,597,9756,352,919
銷售成本(4,906,576)22.495%(4,005,524)(3,610,806)(3,350,737)(2,317,725)
毛利6,738,3163.284%6,524,0665,951,4795,247,2384,035,194
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值599,4723094.969%18,763(91,345)(8,350)253,604
出售項目溢利 / (虧損)------------
其他非經營項目(73,378)25.082%(58,664)23,017484,495--
分佔聯營公司及共同控制公司業績148,720--(25,008)(43,786)113,86261,979
除稅前溢利 / (虧損)2,852,36321.678%2,344,1972,516,8932,785,8322,073,583
稅項(386,304)-13.917%(448,755)(418,642)(380,800)(292,374)
已終止經營業務溢利 / (虧損)------------
非控股權益2,316--(15,444)(18,832)(2,469)11,452
其他項目------------
股東應佔溢利 / (虧損)2,468,37531.297%1,879,9982,079,4192,402,5631,792,661
 
淨財務支出 / (收入)180,242-8.692%197,400117,68718,01197,375
折舊及攤銷503,74828.438%392,210394,912339,519287,061
董事酬金----8,9886,3574,5542,434
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)70.490--53.60058.70067.72052.030
每股派息 (仙)26.000--26.00014.00011.00011.000
派息比率 (%)36.885%--48.507%23.850%16.243%21.142%
每股現金流 ($)0.542--0.6910.5200.5650.423
每股帳面資產淨值 ($)4.641--4.2703.9843.7733.166
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.